|
| Zoely®, a combined oral contraceptive, monophasic pill containing estradiol and nomegestrol acetate |
| A. Pintiaux, U. Gaspard, M. Nisolle |
| Rev Med Liege 2012, 67(3),152-156 |
| Summary : A new combined oral contraceptive called Zoely® has just been marketed in Belgium. It contains nomegestrol acetate, a progestin known for its high contraceptive reliability based on its antigonadotropic power and long half-life. This progestin is associated with estradiol and Zoely® is devoid of ethinyl estradiol, which is the usual component of the majority of combined oral contraceptives and is primarily responsible for thrombotic side effects of the pill. The compositon and type of regimen of this new oral contraceptive contribute to its efficacy and excellent clinical tolerance. |
| COC , Contraception , Estradiol , Nomegestrol acetate – Progestin |
|
PDF |
|
Revue Médicale de Liège
Since 1945
ISSN : 0370-629X Chief Editor: A.Scheen
|
The Medical Review of Liege is a tool for continuous medical training being addressed to students, general practitioners, and specialists.
|
|
||||||